CV Sciences Acquires Elevated Softgels
May 13, 2024
CV Sciences, Inc. has completed an equity purchase of Elevated Softgels, LLC, a GMP-certified manufacturer of encapsulated softgels and tinctures, which will operate as a wholly owned subsidiary. The acquisition (up to $1.0M consideration) is intended to in-source production for CV Sciences' +PlusCBD products, increase sales to current and new clients, and leverage Elevated Softgels' low-MOQ and flexible production capabilities to drive cost savings and growth.
- Buyers
- CV Sciences, Inc.
- Targets
- Elevated Softgels, LLC
- Industry
- Manufacturing
- Location
- Colorado, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
The Cannabist Company Acquires Ciencia Labs Portfolio
December 11, 2024
Retail
The Cannabist Company (formerly Columbia Care) acquired the Ciencia Labs portfolio earlier in 2024 and is launching the Ciencia Labs brand dreamt in Maryland, with additional markets and products planned for 2025. The acquisition expands The Cannabist Company’s branded product offerings and supports broader retail and wholesale distribution across its dispensary and wholesale channels.
-
CV Sciences Acquires Extract Labs
November 21, 2024
Consumer Products
CV Sciences, Inc. entered into a definitive agreement to acquire Extract Labs, Inc., a manufacturer and distributor of premium cannabinoid products, for $400,000 in cash plus $1,000,000 in CV Sciences shares at closing. Additional contingent consideration of up to $600,000 in CV Sciences shares may be earned based on Extract Labs revenue targets post-closing, which is expected in Q1 2025.
-
Bioriginal (Cooke Inc.) Acquires Softgel Co.
November 30, 2023
Food & Beverage
Bioriginal, a subsidiary of Cooke Inc., has acquired Softgel Co., a Grand Junction, Colorado-based softgel and encapsulation manufacturer. The purchase expands Bioriginal’s vertical manufacturing capabilities and secures in‑house softgel production for human and pet nutrition products; terms were not disclosed.
-
Everstone Capital Acquires Controlling Stake in Softgel Healthcare
September 14, 2022
Pharmaceuticals
Everstone Capital has acquired a controlling (majority) stake in Softgel Healthcare Private Limited (SHPL), a Chennai-headquartered CDMO specializing in soft gelatin capsules and probiotics and part of the Madras Pharma Group. The investment will support SHPL's global expansion and capability development across pharmaceutical, nutraceutical and OTC markets, with Everstone partners joining the company's board.
-
High Tide Inc. Acquires 80% of NuLeaf Naturals
November 22, 2021
Consumer Products
High Tide Inc. has agreed to acquire an 80% stake in Denver-based NuLeaf Naturals for US$31.24 million, with a three-year option to buy the remaining 20%. The deal strengthens High Tide's vertical integration and global CBD capabilities by adding NuLeaf's cGMP-certified manufacturing, vegan softgel technology and D2C e-commerce distribution.
-
Cannabinoid Biosciences Acquires CannabidiolHemp
November 25, 2019
Consumer Products
Cannabinoid Biosciences, Inc., a California-based biopharmaceutical subsidiary of Kid Castle, has acquired CannabidiolHemp (CannabidiolHemp.net), a CBD quality aggregator and validator. The purchase is the first of multiple planned acquisitions intended to build a vertically integrated CBD distribution and supply-chain business across the United States and Canada.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.